Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-490-6 | CAS number: 107-43-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The study for oral acute toxicity was conducted according to OECD technical guideline 401, in accordance with GLP. LD50-value in rats was determined to be 11179 mg/kg bw. For acute dermal toxicity, it is unnecessary and unjustified to test the toxicity of betaine, based on the results of skin irritation and skin sensitisation testing. For inhalation toxicity testing, it is scientifically unjustified and technically not possible to carry out the testing based on the properties of the substance.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 NOV 1989 to 30 JAN 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- The study was performed following OECD TG 401 in GLP conditions. T
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals: young adult CD strain female rats, supplied by Charles River (UK) Ltd. Margate, Kent, England, 4 weeks old upon arrival.
Housing: The animals were bred and housed under barriered conditions in a limited access facility. The housing conditions were under daily monitoring (T = 18-25C, relative humidity 40-70%). 12 hours light cycle was employed.
Diet: commercially-available complete pelleted diet (Laboratory animal diet No1, from Biosure, Manea, Cambridgeshire, England) without restrictions, except removal of food 18 hours before administration of test material. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Single oral administration
- Doses:
- 5000, 10000, 12500, 15000 and 20000 mg/kg bodyweight
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Pre-exposure period: Clean cages were prepared the day before delivery of the animals. On arrival, each animal was inspected before being aceepted. All animals were weighed on arrival and the range of bodyweight was recorded. Five animals of the same sex were non-selectively allocated to each cage. Tail tattoos identifying each individual within the cage were made within one day of delivery. The sex of each animal was checked at the same time.An acclimatisation period of atleast six days was allowed. A daily check of the condition of the animals was made. Food was removed at approx 1700 hours on the day before dosing. Each cage was labelled with details of the schedule number, unique cage reference number, treatment regime, animal identification numbers and sex of occupants, Project License umber and responsible licensee. Pre-fasted bodyweight was recorded on the day prior to dosing and ranged for male s107-139g and for females 102-128g.
Administration: given betaine anhydrous dose was dissolved 40 ml /kg bodyweight. Flexible catheter (8-choke) was passed down the oesophagus allowing instillation of the dose into the lumen of the stomach.
Observation period: three separate inspections were made during the first hour after dosing and two further inspections during the remainder of day 1. From day 2 onwards, the animals were inspected twice daily (morning, afternoon). The type, time of onset and duration of reactions to treatment and circumstances of any death were recorded. The bodyweight was recorded at days 1,8 and 15, the test was terminated on day 15.
Necropsy: carcases were stroed at +4C until trained necropsy staff were available. Necropsy was thoroughly studied, all abnormalitites were described or the normal appearance or major organs was confirmed. - Statistics:
- Probit analysis was employed to determine the acute median lethal dosage, 95% confidence interval and slope of the dose response curve of the test material for both sexes. The calculations were performed by the GLIM statistics program using a special macro program.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- >= 11 204 mg/kg bw
- 95% CL:
- >= 8 616 - <= 13 792
- Remarks on result:
- other: Slope (degrees) 88
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 11 148 mg/kg bw
- 95% CL:
- > 9 929 - < 12 367
- Remarks on result:
- other: Slope (degrees) 83
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 11 179 mg/kg bw
- 95% CL:
- > 10 454 - < 11 904
- Remarks on result:
- other: Slope (degrees) 85
- Mortality:
- Dosage (mg/kg), male, female, combined
5000, 0/5, 0/5, 0/10
10000, 0/5, 1/5, 1/10
12500, 5/5, 4/5, 9/10
15000, 5/5, 5/5, 10/10
20000, 5/5, 5/5, 10/10 - Clinical signs:
- other: Following symptoms were recorded per dose per time per animal: lethargy, decreased motor activity, prone posture, ataxia,musculature - tremor, bradypnoea, hyperpnoea, piloerection, ungroomed appearance, hunched posture and death. With 5000 mg/kg: decreas
- Gross pathology:
- Necropsy observations per dose group:
5000 mg/kg: no significant lesions
10000 mg/kg: no significant lesions, one dead female yellow ventral staining, yellow serous fluid in stomach, small intestine and caecum
12500 mg/kg: dead individuals exhibit externally yellow/brown muzzle and perianal staining, internalyl yellow ventral staining, yellow serous fluid in stomach, small intestine and distented caecum
15000 mg/kg: mainly no significant lesions
20000 mg/kg: dead individuals exhibit externally yellow/brown muzzle and perianal staining, internalyl yellow ventral staining, yellow serous fluid in stomach, small intestine, distented caecum and darkened brain. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The defined LD50-value for betaine is 11179 mg/kg (female/male), and it can be considered as practically nontoxic. The LD50-value is well above of the limit for classification (2000 mg/kg).
- Executive summary:
An acute oral toxicity study was perfomed according to OECD Guideline 401. Male and female rats (5/sex) were administered single oral doses of 5000, 10000, 12500, 15000, or 20000 mg/kg. The defined LD50-value for the test substance is 11179 mg/kg (female/male).
Reference
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 11 179 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute toxicity via oral route was determined by an OECD guideline study to be ca. 11200 mg/kg bw, therefore betaine is of low toxicity via this route.
Dermal toxicity does not cause a concern since betaine is widely used in cosmetic preparations to improve human skin health and has been tested safe for this purpose. Therefore, further testing is omitted.
Inhalation toxicity does not cause a concern since it is an unlikely route of exposure due to many physico-chemical properties: particle size is too large (>100 micrometer), betaine is hygroscopic (powder forms clumps easily, making inhalation toxicity studies difficult to perform) and vapour pressure (ca. 0.05 Pa). Taking all this into consideration in addition to the metabolism of betaine and low toxicity via oral route, inhalation toxicity testing is unnecessary and unjustified.
Justification for classification or non-classification
Oral toxicity: Not classified according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, LD50 -value of ca. 11200 mg/kg betaine is above the limit of 2000 mg/kg for classification.
Dermal toxicity: Not classified according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, betaine has been tested for skin irritation and sensitisation and found not to have any irritative or sensitative properties. Additionally, betaine is commonly used in cosmetic products to improve skin health as an anti-irritative.
Inhalation toxicity: Not classified according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, physico-chemical properties and metabolism of betaine indicate that there is no risk associated with inhalation toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)